Literature DB >> 18987645

Human interferon-lambda3 is a potent member of the type III interferon family.

C Dellgren1, H H Gad, O J Hamming, J Melchjorsen, R Hartmann.   

Abstract

Type III interferon (IFN) or IFN-lambda is a recently discovered family of IFNs that signal through the same downstream transcription factors as type I IFN but use a separate receptor complex composed of the IL-10R2 and the unique IFN-lambdaR1 receptor chains. We have established a simple and efficient expression system to produce highly pure and active IFN-lambda of the three human IFN-lambda isoforms (IFN-lambda1, -lambda2 and -lambda3) and used this to compare the biological activity of the different IFN-lambda subtypes. Surprisingly, we found IFN-lambda3 to possess the highest specific activity of the human IFN-lambda subtypes, exhibiting a twofold higher activity than IFN-lambda1 and a 16-fold higher activity than IFN-lambda2. Furthermore, in comparison with the commercially available preparations of IFN-lambda1 and -lambda2, we found our IFN-lambda preparation to be superior in activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987645     DOI: 10.1038/gene.2008.87

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  70 in total

Review 1.  Assessing gene-gene interactions in pharmacogenomics.

Authors:  Hsien-Yuan Lane; Guochuan E Tsai; Eugene Lin
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

2.  Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.

Authors:  Helle Kristiansen; Christina A Scherer; Maralee McVean; Shawn P Iadonato; Susanne Vends; Karthiga Thavachelvam; Thomas B Steffensen; Kristy A Horan; Thomas Kuri; Friedemann Weber; Søren R Paludan; Rune Hartmann
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Yu Zhou; Ting Zhang; Wenzhe Ho
Journal:  J Interferon Cytokine Res       Date:  2014-09-30       Impact factor: 2.607

Review 4.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

5.  Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells.

Authors:  Jiradej Makjaroen; Poorichaya Somparn; Kenneth Hodge; Witthaya Poomipak; Nattiya Hirankarn; Trairak Pisitkun
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

Review 6.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

7.  Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.

Authors:  Harold Dickensheets; Faruk Sheikh; Ogyi Park; Bin Gao; Raymond P Donnelly
Journal:  J Leukoc Biol       Date:  2012-12-20       Impact factor: 4.962

8.  Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Authors:  Julia Diegelmann; Florian Beigel; Kathrin Zitzmann; Artur Kaul; Burkhard Göke; Christoph J Auernhammer; Ralf Bartenschlager; Helmut M Diepolder; Stephan Brand
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1.

Authors:  Zachary J Miknis; Eugenia Magracheva; Wei Li; Alexander Zdanov; Sergei V Kotenko; Alexander Wlodawer
Journal:  J Mol Biol       Date:  2010-10-08       Impact factor: 5.469

10.  Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.

Authors:  Pamela Osterlund; Jaana Pirhonen; Niina Ikonen; Esa Rönkkö; Mari Strengell; Sanna M Mäkelä; Mia Broman; Ole J Hamming; Rune Hartmann; Thedi Ziegler; Ilkka Julkunen
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.